
Manuel Dómine, MD, PhD
@manueldomine
Associate Head Oncology. Fundación Jiménez Díaz. IIS - FJD. Oncohealth Institute @quironsalud Head Thoracic Oncology & Clinical Trials. Professor @UAM_Madrid
ID: 985864516801003520
http://www.quironsalud.es 16-04-2018 12:56:32
1,1K Tweet
2,2K Followers
1,1K Following

Ph3 DeLLphi-304:Tarlatamab vs CTx as 2L treatment for SCLC. Tarlatamab significantly improved mOS: 13.6 vs 8.3 m (HR 0.60) and mPFS: 4.2 vs 3.2 m (HR, 0.72) Very proud to participate in this trial Fundación Jiménez Díaz #IIS-FJD UAM Autónoma Madrid OncoAlert #ASCO2025 @AECAP OncoAlert #ASCO25
